Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Cameron Health’s FDA date is good news for Boston Scientific
Cameron Health landed an April date with the FDA’s circulatory devices panel to review a pre-market approval application for its lead-free subcutaneous implantable cardioverter defibrillator, or S-ICD.
2. Covidien confirms superDimension buyout
Covidien (NYSE:COV) confirmed that it’s agreed to acquire medical device maker superDimension, saying it will pay about $300 million plus possible earnouts in a deal expected to close during the 2nd quarter.
1. Kensey Nash recoups on Angio-Seal settlement with St. Jude
Kensey Nash (NSDQ:KNSY) said it settled a royalties dispute with St. Jude Medical (NYSE:STJ) over the Angio-Seal vascular closure device, sending its shares up more than 20% on Wall Street today.